Medical Oncology Prof. Dr. Abdullah Büyükçelik
✓ Medically verified profileProf. Dr. Abdullah Büyükçelik
✓ Medically verified profile
Quick answer
Prof. Dr. Abdullah Büyükçelik is a Medical Oncology specialist at Acibadem Kayseri Hospital. He treats patients with lung and other thoracic cancers, breast cancer, colorectal cancers, kidney cancer, and gynecological cancers, with additional clinical interests in brain tumors and head and neck cancers.
About Prof. Dr. Abdullah Büyükçelik
Prof. Dr. Abdullah Büyükçelik is a Medical Oncology specialist at Acibadem Kayseri Hospital. His clinical interests include lung and other thoracic cancers, breast cancer, colorectal cancers, kidney cancer, ovarian cancer, endometrial cancer, brain tumors, head and neck cancers, and anal cancer.
He graduated from Istanbul University Istanbul Faculty of Medicine in 1990 and completed Internal Medicine training at Ankara University Faculty of Medicine in 1996, followed by Medical Oncology training in 2001. He became an Associate Professor at Ankara University Faculty of Medicine in 2006 and has worked within Acıbadem Healthcare Services since 2009.
International patients can expect a consultation focused on their diagnosis, treatment history, and individual oncology needs. Prof. Dr. Büyükçelik’s experience includes work in medical oncology and a bone marrow transplantation unit, supporting coordinated care discussions for patients with cancer.
Areas of Expertise
Conditions treated and procedures performed by this specialist.
Education
- 2006Ankara University Faculty of Medicine / Associate Professor
- 2001Ankara University Faculty of Medicine Medical Oncology
- 1996Ankara University Faculty of Medicine Internal Medicine
- 1984–1990İstanbul University İstanbul Faculty of Medicine
Professional Experience
- 2009Acıbadem Healthcare Services
- 2007–2009Ankara University Faculty of Medicine Department of Medical Oncology / Bone Marrow Transplantation Unit
- 2001–2009Ankara University Faculty of Medicine, Department of Medical Oncology
- 1999–2001Ankara University Faculty of Medicine, Medical Oncology Specialization
- 1996–1999Ankara Sevgi Hospital / Internal Medicine Specialist
Professional Memberships
- Febril Nötropeni Association
- Medical Oncology Group
- Internal Medicine Association
- Medical Oncology Association
- Ankara Medical Oncology Association
Selected Publications
- No abstract available. Angiotensin-converting enzyme inhibitors: do they contribute to delayed chemotherapy induced nausea and vomiting? Med Hypotheses, 73, 628-629, (2009) Dogan M, Yalcin B, Ozal FG, Buyukcelik A, Utkan G, Icli F, Dogan L.
- Long-term outcome of mesna, ifosfamide, mitoxantrone, etoposide (MINE) regimen as a consolidation in patients with aggressive non-Hodgkin lymphoma responding to CHOP. Med Oncol, 2009 Sep 29 Dincol D, Buyukcelik A, Dogan M, Akbulut H, Samur M, Demirkazik A, Senler FC, Onur H, Icli F.
- Prognostic significance of serum matrix metalloproteinase 9 (MMP-9) levels in patients with sarcomas. Yaman E, Yalcin B, Utkan G, Akbulut H, Isikdogan A, Sencan O, Buyukcelik A, Demirkazik A, Icli F. UHOD, 18, 79-84, (2008)
- The symptomatic benefit (the clinical benefit response) from the second-line chemotherapy in patients with advanced gastric adenocarcinoma. Şencan O, Buyukcelik A, Yalcin B, Boruban M.C, Akbulut H, Demirkazik A, Senler F.C, Onur H, Icli F. Eur J Cancer Care, 17,26-32, (2008)
- Lung cancer metastasis mimicking gluteal abscess. South Med. J, 100, 334-335, (2007) Tek I, Iyidir OT, Utkan G, Ceyhan K, Buyukcelik A, Yalcin B, Demirkazik A.
- Low molecular weight heparin (LMWH) increases the efficacy of cisplatinum plus gemcitabine combination in advanced pancreatic cancer. Icli F, Akbulut H, Utkan G, Yalcin B, Dincol D, Isikdogan A, Demirkazik A, Onur H, Cay F, Buyukcelik A. J. Surg. Oncol, 95, 507-512, (2007)
- Extranodal Hodgkin disease presenting with gluteal mass and hypercalcemia. South. Med. J. 99, 1149-1150, (2006) Utkan G, Buyukcelik A, Yalcin B, Tek I, Doruk H, Dincol D, Erekul S, Baykara M.
- Expression of p53 protein and DNA flow cytometry in gastric adenocarcinoma: implications in patients treated with adjuvant etoposide, adriamycin and cisplatin. Buyukcelik A, Onur H, Akbulut H, Bulent Y, Ensari A, Utkan G, Onal BS, Icli F. Tumori, 91, 302-308, (2005)
Frequently Asked Questions
What is Dr. Abdullah Büyükçelik's specialty?
Which hospital does Dr. Abdullah Büyükçelik practise at?
What languages can I use when consulting Dr. Abdullah Büyükçelik?
How can I book an appointment with Dr. Abdullah Büyükçelik?
Is an online video consultation available with Dr. Abdullah Büyükçelik?
How many years of experience does Dr. Abdullah Büyükçelik have?
Can international patients arrange treatment with Dr. Abdullah Büyükçelik?
How do I get a second opinion involving Dr. Abdullah Büyükçelik?
A dedicated team, from first message to follow-up
Our international patient office coordinates your appointment, travel and treatment across the Acıbadem network — including 7 JCI-accredited hospitals — and stays with you in your own language, every step of the way.
Schedule your appointment with Prof. Dr. Abdullah Büyükçelik
Choose a date and time that suits you. Our international patient team will check availability and confirm your appointment — usually within 24 hours.
- 1Choose your date & timePick a preferred day and time slot for your visit.
- 2Share your detailsTell us how to reach you and anything we should know.
- 3We confirm with youOur team confirms the appointment by phone or email.
Request your appointment
This request goes directly to this doctor’s schedule.
Your information stays strictly confidential and is used only to arrange your care.
